The global community is facing a number of urgent challenges, such as emerging diseases, epidemics, antimicrobial resistance, ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Pairwise has licensed its Fulcrum® gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply ...

Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Abstract: Graph machine learning has been extensively studied in both academia and industry. Although booming with a vast number of emerging methods and techniques, most of the literature is built on ...

In the early hours of Monday morning, a large part of the internet suddenly stopped working. The origins of the global outage which affected millions around the world —an area of roughly 385 acres in ...

CRISPR Therapeutics could maintain that momentum thanks to progress with its leading candidates. Spotify Technologies' deep ecosystem continues to expand, and the company is turning profitable. Shares ...

Fair attendees in front of an AI sign at the World Artificial Intelligence Conference in Shanghai on July 27, 2025. (Ying Tang/NurPhoto via Getty Images) How we did this This Pew Research Center ...